Literature DB >> 33489474

Current concept for tertiary lymphoid structures in urothelial carcinoma of the bladder: a literature review and our experience.

Milena Gulinac1, Dorian Dikov2, Simeon Lichev3, Tsvetelina Velikova4.   

Abstract

Bladder carcinoma (BC) is one of the most common malignancies of the urinary system in developed countries, with a high number of recurrences. The secondary lymphoid organs (SLO) are crucial for initiating the adaptive immune response. They are developed as a part of a genetically preprogrammed process during embryogenesis. However, SLO's organogenesis can be reduplicated de novo in other tissues by a process termed lymphoid neo-genesis, giving rise to tertiary lymphoid structures (TLS). These well-organized lymphoid structures in cancer are essential modulators of cancer immunologic response, and the histological examination of TLS gave a new strategy for cancer immunotherapy. This review explores the biological and histological characteristics of TLS in muscle non-invasive and invasive BC. AJCEI
Copyright © 2020.

Entities:  

Keywords:  TRL; Tertiary lymphoid structures; bladder carcinoma; immunology; immunotherapy; urothelial carcinoma

Year:  2020        PMID: 33489474      PMCID: PMC7811926     

Source DB:  PubMed          Journal:  Am J Clin Exp Immunol


  41 in total

Review 1.  T cell exclusion, immune privilege, and the tumor microenvironment.

Authors:  Johanna A Joyce; Douglas T Fearon
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

Review 2.  Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.

Authors:  Marie-Caroline Dieu-Nosjean; Nicolas A Giraldo; Hélène Kaplon; Claire Germain; Wolf Herman Fridman; Catherine Sautès-Fridman
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

3.  Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis.

Authors:  Sanjiv A Luther; Afshin Bidgol; Diana C Hargreaves; Andrea Schmidt; Ying Xu; Jyothi Paniyadi; Mehrdad Matloubian; Jason G Cyster
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

4.  Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1.

Authors:  Daniel S Chen; Bryan A Irving; F Stephen Hodi
Journal:  Clin Cancer Res       Date:  2012-10-19       Impact factor: 12.531

Review 5.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

Review 6.  Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation.

Authors:  Francesca Barone; David H Gardner; Saba Nayar; Nathalie Steinthal; Christopher D Buckley; Sanjiv A Luther
Journal:  Front Immunol       Date:  2016-11-08       Impact factor: 7.561

Review 7.  Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?

Authors:  Emily Jayne Colbeck; Ann Ager; Awen Gallimore; Gareth Wyn Jones
Journal:  Front Immunol       Date:  2017-12-19       Impact factor: 7.561

Review 8.  High Endothelial Venules and Other Blood Vessels: Critical Regulators of Lymphoid Organ Development and Function.

Authors:  Ann Ager
Journal:  Front Immunol       Date:  2017-02-03       Impact factor: 7.561

Review 9.  Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy.

Authors:  Liangbin Lin; Xiang Hu; Huiyuan Zhang; Hongbo Hu
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

10.  Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22.

Authors:  Hiroaki Takatori; Yuka Kanno; Wendy T Watford; Cristina M Tato; Greta Weiss; Ivaylo I Ivanov; Dan R Littman; John J O'Shea
Journal:  J Exp Med       Date:  2008-12-29       Impact factor: 14.307

View more
  1 in total

1.  Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.

Authors:  Tsukasa Masuda; Nobuyuki Tanaka; Kimiharu Takamatsu; Kyohei Hakozaki; Ryohei Takahashi; Tadatsugu Anno; Ryohei Kufukihara; Kazunori Shojo; Shuji Mikami; Toshiaki Shinojima; Kazuhiro Kakimi; Tatsuhiko Tsunoda; Eriko Aimono; Hiroshi Nishihara; Ryuichi Mizuno; Mototsugu Oya
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 12.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.